Boutique Venture Partners3 E BioventuresSmartlensStanford UniversityGraphene VenturesSophia Innovation CapitalPlaisance Capital ManagementWilson Sonsini InvestmentsAmbit Health Ventures
Description
Smartlens, Inc., a clinical-stage ophthalmic technology company, has closed an oversubscribed $6.1M Series A equity financing round to advance regulatory clearance for miLens, a novel, electronics-free, soft contact lens for monitoring diurnal intraocular pressure (IOP).
Who to call at Smartlens, and when
A new round usually means Smartlens is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Smartlens raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Smartlens, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Smartlens. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Smartlens
Location
Mountain View, California, United States
About
Smartlens is developing novel solutions for managing glaucoma and other anterior segment eye diseases. We are transforming traditional eye care into personalized, proactive disease management through our technologies addressing unmet needs in eye care since the 1950s, with solutions designed for millions of patients worldwide.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Smartlens raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Mountain ViewManufacturingInformation TechnologyBiotechnologyHealth CareTherapeutics